APA (7th ed.) Citation

LAH, B., RL, J., A, O., A, C., DF, C., & DM, B. (2024). Genetic variation on dolutegravir pharmacokinetics and relation to safety and efficacy outcomes: A systematic review. Pharmacogenomics, 25(14-15), 623. https://doi.org/10.1080/14622416.2024.2441104

Chicago Style (17th ed.) Citation

LAH, Bevers, Jensen RL, Owen A, Colbers A, Carr DF, and Burger DM. "Genetic Variation on Dolutegravir Pharmacokinetics and Relation to Safety and Efficacy Outcomes: A Systematic Review." Pharmacogenomics 25, no. 14-15 (2024): 623. https://doi.org/10.1080/14622416.2024.2441104.

MLA (9th ed.) Citation

LAH, Bevers, et al. "Genetic Variation on Dolutegravir Pharmacokinetics and Relation to Safety and Efficacy Outcomes: A Systematic Review." Pharmacogenomics, vol. 25, no. 14-15, 2024, p. 623, https://doi.org/10.1080/14622416.2024.2441104.